A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

Clinical trial NCT03629756 · COMPLETED

Trial details

NCT number: NCT03629756
Sponsor: Arcus Biosciences, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Squamous Cell Carcinoma of the Head and Neck Breast Cancer Colorectal Cancer Melanoma Bladder Cancer Ovarian Cancer Endometrial Cancer Merkel Cell Carcinoma GastroEsophageal Cancer Renal Cell Carcinoma Castration-resistant Prostate Cancer

Start date: 2018-07-24
Primary completion: 2021-08-18
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.